China approves J&J's oral psoriasis pill, says drugmaker
China approves J&J's oral psoriasis pill, says drugmaker SHANGHAI, Aug 27 (Reuters) - Johnson & Johnson JNJ.N said on Thursday that its oral drug icotrokinra was approved in China for moderate-to-severe plaque psoriasis.
(Reporting by Andrew Silver in Shanghai
Editing by Tomasz Janowski)
Recent news on Johnson & Johnson
See all newsEli Lilly hits record high as healthcare stocks rally
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived (updated)
Brief: Johnson & Johnson Announces New Data For Tremfya
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived
Health Rounds: Glucose monitoring devices for type 2 diabetes benefit even those not on insulin